Share

    


Home / Search Results

Search Results

You searched for:

    Displaying results 1 - 20 of 24
  • 1
  • 2
  • »
Before opening the ACCC 49th Annual Meeting & Cancer Center Business Summit to its membership, ACCC held two pre-conference events on Wednesday, March 8. Learn more about what was discussed among invited speakers during these events.
For 2023, ACCC members have identified four core areas of focus (e.g., reimbursement, utilization management, provider-patient choice), among a larger set of issues and concerns, that the association will be supporting this year.
In recognition of American Pharmacists Month, ACCCBuzz spoke to Dr. Sarah Hudson-DiSalle at The James Cancer Hospital to learn more about her role on the cancer care team.
In recognition of Pharmacy Technician Day today (October 18), ACCCBuzz spoke with Danielle Duy, CPhT, to learn more about her role on the multidisciplinary cancer care team.
The ACCC 39th National Oncology Conference opened with two pre-conferences, covering financial advocacy in oncology and the future of cancer care. Learn what care delivery may look like in 2040 and how ACCC is supporting cancer programs and practices through its Financial Advocacy Network.
Around half of patients with cancer and survivors of cancer are dealing with financial toxicity, and one of the best ways to handle this is through financial navigation. For 18 years, the Patient Access Network (PAN) Foundation has helped patients pay their out-of-pocket treatment costs.
Dr. David Eagle shares why grassroot advocacy efforts are so important to furthering health equity and person-centered care in oncology, including how state-based efforts curbed harmful pharmacy benefit manager practices in New York.
ACCC Director Cancer Care Delivery and Health Policy Matt Devino, MPH, lays out the four key differences between the OCM and EOM that interested applicants need to consider.
Advocating on behalf of their patients and programs, ACCC members from 14 states participated in Virtual Hill Day, speaking with Congress and their staff on key legislation asks regarding access to care, telehealth, prior authorizations, and more.
Looking to the future, CMS is seeking to leverage the agency’s strength to advance health equity; drive high-quality, person-centered care; and promote the affordability and sustainability of the Medicare Program.
ACCC has partnered with several of its oncology state societies to establish the Appalachian Community Cancer Alliance—a key effort to address disparities in cancer screening and care delivery in the region.
The last time I wrote for ACCCBuzz, I shared that I would try to find nuggets of wisdom that were inspiring me in my work and day-to-day life in hope of inspiring you. One topic that keeps coming to my mind: building trust among our teams and colleagues.
ACCC Board Member Wendi Waugh tells ACCCBuzz about her experience speaking at and attending the in-person Oncology Reimbursement Meetings this spring, covering topics from financial advocacy in oncology to formulary management and networking with colleagues to address workforce concerns at your cancer center.
The final post in a three-blog series, ACCCBuzz spoke to Megan Morava, PA-C, and Alexandra Greenawalt who share how one independent oncology practice and local community center are taking action to improve equitable cancer care delivery at the local level.
The second post in a three-blog series, ACCCBuzz shares how Carolina Blood and Cancer Care Associates' NOLA initiative is addressing access to care, clinical trials, biomarker testing, and more.
After convening its members, sponsors, and industry partners in Washington, DC, for the first time since the dawn of COVID-19, ACCC Buzz shares a glimpse of the activities and insights the final day at ACCC’s 48th Annual Meeting and Cancer Center Business Summit.
Hear from a pharmacist and an oncology operations manager as they share how the digital Patient Assistance Guide tool can help you find resources in less time so patients can access—and better afford—their cancer treatments.
Because transportation disruptions can result in missed appointments, treatment delays, and potentially adverse health outcomes, we must help ensure that our patients have access to safe and reliable means of transportation.
As we turn the corner toward 2022, for oncology to drive equity forward: We need every member and every discipline, patient, leader, payer, industry partner, and innovator working together to provide the most equitable care possible in a sustainable way.
In addition to the global pandemic, ongoing lawsuits from referenced biologics' manufacturers suing biosimilar manufacturers are having a negative impact on the development and approval of new biosimilars.
    Displaying results 1 - 20 of 24
  • 1
  • 2
  • »